Industry News
Quantum technology for imaging life at the nanoscale
Researchers have demonstrated a way to detect and image electronic spins non-invasively with ambient sensitivities and resolution orders of magnitude never before achieved. [ + ]
The origin of cancer-associated cells revealed?
Japanese researchers have revealed what they claim to be the origins of cancer-associated fibroblasts — cells that play a key role in cancer progression — in a breakthrough that could lead to new approaches to cancer treatment. [ + ]
BioScience Managers invests in REX Bionics
Australian life sciences investment firm BioScience Managers has chosen a robotic exercise assist device (REX) as its first investment for the Biomedical Translation Fund. [ + ]
Merck to co-lead global cancer big data alliance
Merck is collaborating with independent not-for-profit Project Data Sphere to jointly lead the Global Oncology Big Data Alliance (GOBDA). [ + ]
2017 Medical Devices Fund winners announced
The NSW Government announced the winners of the Medical Devices Fund at a ceremony held at Parliament House. [ + ]
New chip design for quantum computing
UNSW engineers have invented a new architecture for quantum computing that promises to make the large-scale manufacture of quantum chips both cheaper and easier than previously thought possible. [ + ]
Medtech entrepreneur Lusia Guthrie joins BioMelbourne Network board
BioMelbourne Network has announced the appointment of Lusia Guthrie to its board of directors. With over 35 years in pharmaceutical and bioscience industries, Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. [ + ]
Inaugural PluS Alliance Prize winners announced
The PLuS Alliance has announced the winners of the inaugural PLuS Alliance Prize, which recognises innovation in both research and education. [ + ]
Switching off immune cells to fight allergies
Queensland researchers are a step closer to developing new medicines for treating inflammatory diseases, including allergies such as rhinitis, itchy hives, asthma, eczema and dermatitis. [ + ]
Emerson joins with Enterprise System Partners to accelerate product manufacturing pipelines
Emerson has selected Enterprise System Partners (ESP), a consulting and project engineering company, to collaborate with and assist life sciences manufacturers in implementing the Syncade manufacturing execution system (MES). [ + ]
Over 150 new gene variants identified in osteoporosis study
An international group of scientists is homing in on a potential treatment for osteoporosis, after performing the largest ever genetic study of the common age-related bone-thinning disease. [ + ]
A concord of chemistry and crystallography
Researchers have released a theoretical approach to explain inconsistencies between crystallographic and chemical experimental data in the apparent transformation of a pyrochlore to defect fluorite in La2Zr2O7. [ + ]
US food company Neogen acquires UQ's animal genomics lab
Global US food and animal safety company Neogen Corporation has acquired the assets of The University of Queensland Animal Genetics Laboratory (AGL). [ + ]
Caucasian ovarian cancer patients should stick to standard dosing, study finds
European women with ovarian cancer should stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to the results of the phase III ICON8 trial. [ + ]
M2 facility to keep Australia's medtech industry healthy
CSIRO, Monash University and the Monash Health Translation Precinct (MHTP) have announced the creation of M2 — a new facility that combines technology, research and medical science. [ + ]
